The U.S. will likely emerge the winner in a "cold currency war" that is heating up, an expert said.Currenciesread more
These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Tariffs are the only instrument left for addressing China's systematic and excessive surpluses on its U.S. trades, writes Michael Ivanovitch.US Economyread more
The U.K. will find out who its next prime minister will be this week as voting within the U.K.'s ruling Conservative Party comes to a close.Europe Politicsread more
In its latest attempt to build market credibility, China on Monday launched the Science and Technology Innovation Board, or "STAR Market," on which 25 companies were listed.China Economyread more
When Cathy Hsu and Tony Hsieh wanted to build an English language app for Chinese children, they decided to follow Facebook and Google's lead.Start-upsread more
Stocks in Asia were lower on Monday, as shares on a new Nasdaq-style technology board on the Shanghai Stock Exchange skyrocketed on their debut day.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
The billionaire hedge fund activist has been betting against Herbalife for more than four years, accusing the nutritional supplement company of running a pyramid scheme.
Herbalife has always denied those allegations.
"We've been entirely right on our Herbalife investment in terms of the fundamentals of the business. We've been wrong on the share price. A big part of that is the fact that companies repurchase a huge amount of shares," Ackman said on CNBC's "Squawk Box. "
"A big part of this is trying to cause a short squeeze. We just did something, which we will announce later this afternoon," he added. "What we did recently in the last few weeks is we converted our entire [Herbalife] short position into a put position. And as a result there is no longer an opportunity to squeeze Pershing Square. "
The investor said his firm has 3 percent of its capital in derivatives betting against Herbalife's share price.
"Ultimately the [negative] fundamentals will prove right," he said. "Because it is in the form of derivatives, the upside is great and we don't have these risks associated with a short squeeze."
Herbalife did not immediately respond to a request for comment.
The company's shares are up 51 percent year to date through Tuesday versus the S&P 500's 15 percent return.
Pershing Square has been underperforming the stock market this year. The fund is down 1.2 percent year-to-date return through Oct. 24, according to its website.
Ackman also revealed in the interview that his fund's return recently turned positive for the year.